CD4 and cancer: On the other hand, CD4+ Th2 cells, CD4+ T regulatory (TReg) cells, type 2 NK T cells, myeloid-derived suppressor cells, immature DCs, and M2 macrophages could suppress antitumor immunity and promote cancer progression34,35.